| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| anti-glypican-2 CAR T-cell therapy (Childrens Hospital of Philadelphia/Kite Pharma) | Phase 1 Clinical | Childrens Hospital of Philadelphia | Rhabdomyosarcoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma | 詳細 | |
| GPC2 CAR-T cell therapy(Childrens Hospital of Philadelphia/Tmunity Therapeutics) | TmGPC2-01-CAR-T | Phase 1 Clinical | Childrens Hospital of Philadelphia | Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma | 詳細 |